958 filings
Page 22 of 48
SC 13D/A
NVS
Novartis AG
28 Nov 17
Arrowhead Pharmaceuticals, Inc.
12:00am
5
Kenneth Allen Myszkowski
6 Oct 17
ARROWHEAD PHARMACEUTICALS / Kenneth Allen Myszkowski ownership change
12:00am
10-Q
2017 Q3
ARWR
Arrowhead Pharmaceuticals, Inc.
Quarterly report
3 Aug 17
12:00am
8-K
ARWR
Arrowhead Pharmaceuticals, Inc.
3 Aug 17
Arrowhead Reports Fiscal 2017 Third Quarter Results
12:00am
SC 13G/A
BLK
BlackRock, Inc.
10 Jul 17
Arrowhead Pharmaceuticals, Inc.
12:00am
8-K
ARWR
Arrowhead Pharmaceuticals, Inc.
3 May 17
Arrowhead Reports Fiscal 2017 Second Quarter Results
12:00am
10-Q
2017 Q2
ARWR
Arrowhead Pharmaceuticals, Inc.
Quarterly report
3 May 17
12:00am
4
ARWR
Arrowhead Pharmaceuticals, Inc.
14 Apr 17
ARROWHEAD PHARMACEUTICALS / Christopher Richard Anzalone ownership change
12:00am
8-A12B
ARWR
Arrowhead Pharmaceuticals, Inc.
23 Mar 17
Registration of securities on exchange
12:00am
8-K
ARWR
Arrowhead Pharmaceuticals, Inc.
23 Mar 17
Entry into a Material Definitive Agreement
12:00am
SC 13G/A
ARWR
Arrowhead Pharmaceuticals, Inc.
14 Feb 17
Arrowhead Pharmaceuticals, Inc.
12:00am
SC 13G/A
Baker Bros. Advisors LP
14 Feb 17
Arrowhead Pharmaceuticals, Inc.
12:00am
10-Q
2017 Q1
ARWR
Arrowhead Pharmaceuticals, Inc.
Quarterly report
6 Feb 17
12:00am
8-K
ARWR
Arrowhead Pharmaceuticals, Inc.
6 Feb 17
Arrowhead Reports Fiscal 2017 First Quarter Results
12:00am
EFFECT
ARWR
Arrowhead Pharmaceuticals, Inc.
3 Feb 17
Notice of effectiveness
12:00am
EFFECT
ARWR
Arrowhead Pharmaceuticals, Inc.
3 Feb 17
Notice of effectiveness
12:00am
CORRESP
ARWR
Arrowhead Pharmaceuticals, Inc.
1 Feb 17
Correspondence with SEC
12:00am
CORRESP
ARWR
Arrowhead Pharmaceuticals, Inc.
1 Feb 17
Correspondence with SEC
12:00am
DEF 14A
ARWR
Arrowhead Pharmaceuticals, Inc.
Definitive proxy
1 Feb 17
12:00am
DEFA14A
ARWR
Arrowhead Pharmaceuticals, Inc.
1 Feb 17
Additional proxy soliciting materials
12:00am